Chambéry

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Chronic myeloid leukaemia1 trial
• Coronary artery disease1 trial
• Familial hypercholesterolaemia1 trial
• Multiple sclerosis1 trial
• Myeloproliferative neoplasms1 trial
• Peripheral artery disease1 trial

Phase

• Phase 41 trial

Status

• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Novartis Pharmaceuticals4 trials

Running trials

• Active, not recruiting

  Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

  NCT06092879· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in France

  NCT06157086· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  A Study of Real-world Use and Effectiveness of Cytoreductive Strategies for the Treatment of Second-line Polycythemia Vera in France

  NCT07839858· Novartis Pharmaceuticals· Source

• Completed

  Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia

  NCT05192941· Phase 4· Novartis Pharmaceuticals· Source